Science Weekly

Every year, the world’s leaders gather for the UN climate change conference. At Cop28, they will be faced with two stark warnings from scientists: we are likely to breach 1.5C warming above pre-industrial levels in the next five years, and we are on course to reach 2.7C of warming by the end of the century. Progress has never been more critical and this year it lies in the hands of the United Arab Emirates, a country that has plans to expand its already extensive oil and gas productions. With six months to go, Madeleine Finlay talks to environment correspondent Fiona Harvey about Cop28’s hosts and president, why this year is particularly key, and how close we are getting to irreversible climate tipping points. Help support our independent journalism at theguardian.com/sciencepod

Since it was introduced to the UK in 1850, Japanese knotweed has gone from novel ornamental plant to rampant invasive species. Madeleine Finlay speaks to journalist Samanth Subramanian about the huge costs associated with finding it on a property, and Dr Sophie Hocking explains what the plant, and our attempts to control it, might be doing to the environment.. Help support our independent journalism at theguardian.com/sciencepod

We now know that global temperatures are likely to temporarily rise by more than 1.5C above pre-industrial levels in the next five years. Breaching this crucial threshold will give humanity an insight into what the next few decades could bring. It will undoubtedly have serious consequences in all aspects of our lives, including what we eat. In the second of our special series of episodes looking at what a future world might look like, science editor Ian Sample explores how our diets could change as the Earth heats up. Ian talks to Kew’s kitchen gardener Helena Dove about climate-resilient vegetables, visits Tiziana di Costanzo’s insect farm to try mealworms and crickets, and hears from Solar Food’s CEO, Pasi Vainikka, about making food from bacteria, electricity and air. Help support our independent journalism at theguardian.com/sciencepod

A first-of-its-kind non-hormonal drug to treat hot flushes has been approved in the US. Targeting connections in the brain that change during menopause, the drug, called fezolinetant, could provide relief for those who aren’t able to take hormonal replacement therapy. Madeleine Finlay speaks to endocrinologist and menopause specialist Prof Annice Mukherjee to find out what we know about the mechanism that causes hot flushes, how this new drug works, and what it might mean for those experiencing menopause in the future.. Help support our independent journalism at theguardian.com/sciencepod

More than 40 leading scientists have resigned en masse from the editorial board of a top science journal in protest at what they describe as the ‘greed’ of the publisher. Ian Sample speaks to correspondent Hannah Devlin about the remarkably lucrative business of scientific publishing, hears from Prof Chris Chambers about what was behind the recent mass resignation, and finds out why researchers are demanding change. Help support our independent journalism at theguardian.com/sciencepod

The pioneering IVF procedure known as mitochondrial donation therapy (MDT) could prevent children from being born with devastating mitochondrial diseases. Madeleine Finlay speaks to Prof Darren Griffin, an expert in genetic diseases and reproduction, about how MDT works, the ethical considerations attached, and what techniques like it could mean for the future of reproduction. Help support our independent journalism at theguardian.com/sciencepod

Psychedelic drugs have long been been used for their mind-altering effects. Now, they are making their way into western medicine as a treatment for mental health disorders. From July, psychiatrists in Australia will be able to prescribe MDMA for post-traumatic stress disorder, making it the first country in the world to recognise psychedelics as medicines. The US could soon follow, with plans for the US Food and Drug Administration to be asked for approval to treat PTSD with MDMA this year. Ian Sample speaks to correspondent Hannah Devlin about how the science behind psychedelic therapy has progressed, and hears from Prof Celia Morgan about what treatment is actually like, what we know about the risks and what’s left to learn. Help support our independent journalism at theguardian.com/sciencepod

For the first time, researchers have found a way to non-invasively translate a person’s thoughts into text. Using fMRI scans and an AI-based decoder trained on a precursor to ChatGPT, the system can reconstruct brain activity to interpret the gist of a story someone is listening to, watching or even just imagining telling. Ian Sample speaks to one of the team behind the breakthrough, the neuroscientist Dr Alex Huth, to find out how it works, where they hope to use it, and whether our mental privacy could soon be at risk. Help support our independent journalism at theguardian.com/sciencepod

As the planet warms, and intense heatwaves become the norm, our urban environments need a radical rethink to keep them habitable. So what do we want the cities of the future to look like? In the first of our special series of episodes looking at what a future world could look like, Madeleine Finlay speaks to author and historian Ben Wilson, Prof Jessica Davies and Prof Diane Jones Allen about how to create cities that are fairer, greener and more self-reliant.. Help support our independent journalism at theguardian.com/sciencepod

The environmental law charity ClientEarth and 13 other groups headed into a Flemish court this week in an effort to stop Ineos building a petrochemical plant that would be the biggest project of its kind in Europe for 30 years. Madeleine Finlay hears from correspondent Sandra Laville about how plastics are made, the environmental and health impacts of the process and what needs to be done to get a handle on plastic pollution. Help support our independent journalism at theguardian.com/sciencepod